Alcon’s ALC Surgical business continues to gain from its diverse portfolio and incremental innovation. Within Vision Care, the company is registering solid growth, banking on strong sales of its ...

Notable recent launches from Alcon include PanOptix and Vivity, which were launched in the U.S. in 2019 and 2021, respectively. PanOptix is the first trifocal IOL approved by the FDA, and Vivity ...

Notable recent launches from Alcon include PanOptix and Vivity, which were launched in the U.S. in 2019 and 2021, respectively. PanOptix is the first trifocal IOL approved by the FDA, and Vivity ...

Alcon Inc. ALC gains on strong market share gains. The company’s broad pipeline and focus on research and innovation are impressive. Yet, a challenging international market with geopolitical pressure ...

particularly UNITY VCS and PanOptix Pro. Management flagged foreign exchange headwinds and front-loaded investments as potential risks to 2025 guidance. Alcon’s Q4 2024 performance underscores ...

Alcon Inc (NYSE:ALC) is preparing to launch a rich product pipeline, including the Unity VCS faco device and PanOptix Pro PCIOL, which are expected to drive future growth. The company's contact ...

Alcon Inc. ALC gains on strong market share ... Within the Surgical business, of late, the company’s flagship lenses, Vivity and PanOptix, continue to lead the category in the United States ...